Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Isoplexis in June, 2019 for $2,849,529.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA210841-04 | Phase II | 2,849,529 | June 17, 2019 | |||||||
A SBIR Phase II contract was awarded to Isoplexis in August, 2019 for $1,960,275.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA224505-02 | Phase II | 1,960,275 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Isoplexis in June, 2020 for $999,615.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG067878-01 | Phase II | 999,615 | June 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Isoplexis in September, 2018 for $224,633.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA224505-01A1 | Phase I | 224,633 | September 12, 2018 | |||||||
A SBIR Phase I contract was awarded to Isoplexis in September, 2019 for $224,947.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG066022-01 | Phase I | 224,947 | September 30, 2019 | |||||||
A SBIR Phase I contract was awarded to Isoplexis in April, 2018 for $163,731.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HG010025-01 | Phase I | 163,731 | April 16, 2018 | |||||||
A SBIR Phase II contract was awarded to Isoplexis in August, 2019 for $1,985,450.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 9R44CA243949-02 | Phase II | 1,985,450 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Isoplexis in August, 2018 for $224,895.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS108866-01 | Phase I | 224,895 | August 15, 2018 |